President Trump’s price relief memorandum calls for reducing unnecessary administrative costs and rent-seeking behavior in health care. With federal agencies empowered to gather information and potentially drive reforms to eliminate wasteful spending, CHIR’s Christine Monahan discusses how federal agencies can effectively implement this directive by investigating intermediaries like pharmacy benefit managers (PBMs) and third-party administrators (TPAs) that increase consumer and employers costs through profit-driven practices.

The Trump Administration is considering a change that would cut financial assistance for health insurance by removing protections for people whose income increases during the year, potentially resulting in many individuals having to repay the subsidy they received. CHIR’s Karen Davenport discusses what this would mean, specifically for people with incomes below 400% of the poverty level.

A snowy first week of January gave us plenty of time to read some of the last research from 2024. This month we read about prescription drug pricing and the impacts of rebates on consumers, as well as market shares of Medicare Advantage carriers.

In a recently published JAMA article, CHIR’s Maanasa Kona discusses the steps states can take to improve the financial assistance programs offered by hospitals, as well as the need for better state oversight of hospitals’ eligibility criteria and decision-making.

The Centers for Medicare & Medicaid Services (CMS) has introduced a new option for states to update their essential health benefits (EHB) benchmark plan to include routine adult dental coverage, aiming to address disparities in oral health outcomes, particularly for low-income and minority adults. In their latest Expert Perspective for the State Health & Value Strategies program, CHIR’s JoAnn Volk and Manatt’s Tara Straw discuss considerations for states weighing this addition.

Many Americans struggle with high healthcare costs, leading state policymakers to explore transparency measures to lower prices. While transparency alone has limited impact on cost reduction, states are innovating by increasing transparency in areas like provider ownership, billing practices, and price data, which can inform broader policy solutions and have bipartisan support, paving the way for more effective cost-containment strategies. In their latest article for CHIRblog, CHIR experts Stacey Pogue and Nadia Stovicek explore transparency options for state policymakers.

In recent years, federal price transparency rules have required hospitals and health plans to publicly post their prices. However, challenges persist with data access and use, limiting the data’s effectiveness for consumers and policymakers. Two bipartisan bills in Congress seek to strengthen these rules. CHIR experts Stacey Pogue and Nadia Stovicek discuss the federal price transparency landscape in their latest article for CHIRblog.